CD8A and neoplasm: Among the most potent effectors in this response are antigen-specific CD8+ cytotoxic T lymphocytes (CTLs), which can directly lyse tumor cells upon recognition of peptides presented on MHC class I molecules on dendritic cells (DCs) and receiving help through cytokine-mediated signaling networks from CD4+ helper T cells [67].